Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine M Wolfrum

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Psychopharmacology|October 22, 2013
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and functionAmy J Eshleman, Michael J Forster, Katherine M Wolfrum, et al.
Biochemical Pharmacology|April 16, 2013
Substituted methcathinones differ in transporter and receptor interactionsAmy J Eshleman, Katherine M Wolfrum, Meagan G Hatfield, et al.
Biochemical Pharmacology|September 28, 2018
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT<sub>2A</sub> receptorsAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Biochemical Pharmacology|October 22, 2020
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Neuropharmacology|May 15, 2025
Pharmacology of newly identified nitazene variants reveals structural determinants of affinity, potency, selectivity for mu opioid receptorsLaura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
Psychopharmacology|February 4, 2014
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroAaron Janowsky, Amy J Eshleman, Robert A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2020
Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and TransportersRandy Torralva, Amy J Eshleman, Tracy L Swanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2023
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)<sub>2A</sub> Receptor (5-HT<sub>2A</sub>R), 5-HT<sub>2C</sub>R, 5-HT<sub>1A</sub>R, and Serotonin TransporterLaura B Kozell, Amy J Eshleman, Tracy L Swanson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Psychopharmacology|October 22, 2013
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and functionAmy J Eshleman, Michael J Forster, Katherine M Wolfrum, et al.
Biochemical Pharmacology|April 16, 2013
Substituted methcathinones differ in transporter and receptor interactionsAmy J Eshleman, Katherine M Wolfrum, Meagan G Hatfield, et al.
Biochemical Pharmacology|September 28, 2018
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT<sub>2A</sub> receptorsAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Biochemical Pharmacology|October 22, 2020
Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2016
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and ReleaseAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Neuropharmacology|May 15, 2025
Pharmacology of newly identified nitazene variants reveals structural determinants of affinity, potency, selectivity for mu opioid receptorsLaura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
Psychopharmacology|February 4, 2014
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroAaron Janowsky, Amy J Eshleman, Robert A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2020
Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and TransportersRandy Torralva, Amy J Eshleman, Tracy L Swanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2023
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)<sub>2A</sub> Receptor (5-HT<sub>2A</sub>R), 5-HT<sub>2C</sub>R, 5-HT<sub>1A</sub>R, and Serotonin TransporterLaura B Kozell, Amy J Eshleman, Tracy L Swanson, et al.
Pageof 2